Lindbrook Capital, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 160 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is 3.56 and the average weighting 0.7%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$2,096127
+746.7%
0.00%
Q3 2022$0
-100.0%
15
-68.1%
0.00%
Q2 2022$1,000
-75.0%
47
-29.9%
0.00%
-100.0%
Q1 2022$4,000
+100.0%
67
+103.0%
0.00%
Q4 2021$2,000
-33.3%
330.0%0.00%
-100.0%
Q3 2021$3,000
-25.0%
330.0%0.00%0.0%
Q2 2021$4,0000.0%330.0%0.00%0.0%
Q1 2021$4,000
-20.0%
330.0%0.00%0.0%
Q4 2020$5,000
+150.0%
330.0%0.00%0.0%
Q3 2020$2,0000.0%330.0%0.00%0.0%
Q2 2020$2,000330.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders